Impairment of motor coordination, or ataxia, is a prominent effect of alcohol ingestion in humans. To date, many models have been created to examine this phenomenon in animals. Evidence suggests that the tasks thought to measure this behavior in mice actually measure different components of this complex trait. We have characterized the parallel rod floor apparatus to quantify ethanol‐induced motor incoordination. Using genetically heterogeneous mice, we evaluated the influence of rod diameter and inter‐rod distance on dose‐related ethanol‐induced motor incoordination to select parameters that optimized testing procedures. We then used the DBA/2J and C57BL/6J inbred strains of mice to examine the effect of 2 g/kg of ethanol, by serially testing mice on two floor types, separated by 1 week. Finally, we tested eight inbred strains of mice on four floor types to examine patterns of strain sensitivity to 2 g/kg of intraperitoneal ethanol and determined the test parameters that maximized strain effect size. Motor incoordination varied depending on the floor type and strain. When data from strain 129S1/SvlmJ were removed from the analyses because of their extreme behavior, the greatest strain effect size was observed on one floor type during the first 10 min of testing after 2 g/kg of intraperitoneal ethanol. These findings suggest that the parallel rod floor apparatus provides a useful means for examining ethanol‐induced motor incoordination in mice but that specific testing procedures are important for optimizing detection of motor incoordination and genetic influences.
6 August 2015 in Alcohol, Clinical and Experimental Research
Background: The γ‐aminobutyric acid (GABA) system is implicated in the neurobiological actions of ethanol, and pharmacological agents that increase the activity of this system have been proposed as potential treatments for alcohol use disorders. As ethanol has its own GABA mimetic properties, it is critical to determine the mechanism by which GABAergic drugs may reduce the response to ethanol (i.e., via an inhibition or an accentuation of the neurobiological effects of ethanol).Methods: In this study, we examined the ability of 3 different types of GABAergic compounds, the GABA reuptake inhibitor NO‐711, the GABAAreceptor agonist muscimol, and the GABABreceptor agonist baclofen, to attenuate the locomotor stimulant response to ethanol in FAST mice, which were selectively bred for extreme sensitivity to ethanol‐induced locomotor stimulation. To determine whether these compounds produced a specific reduction in stimulation, their effects on ethanol‐induced motor incoordination were also examined.Results: NO‐711, muscimol, and baclofen were all found to potently attenuate the locomotor stimulant response to ethanol in FAST mice. However, both NO‐711 and muscimol markedly increased ethanol‐induced ataxia, whereas baclofen did not accentuate this response.Conclusions: These results suggest that pharmacological agents that increase extracellular concentrations of GABA and GABAAreceptor activity may attenuate the stimulant effects of ethanol by accentuating its intoxicating and sedative properties. However, selective activation of the GABABreceptor appears to produce a specific attenuation of ethanol‐induced stimulation, suggesting that GABABreceptor agonists may hold greater promise as potential pharmacotherapies for alcohol use disorders.
1 April 2016 in Pharmacology Biochemistry and Behavior